Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Bad
|
New words:
add, antihistamine, automobile, backup, behavior, Building, Carolina, chairman, compliant, Concept, cough, database, disadvantage, divest, encouraging, entirety, environment, exact, explicitly, extraordinary, gather, GLP, hydrocodone, instance, lab, lesser, leukotriene, met, montelukast, nongovernmental, Noteholder, notify, Oversight, paragraph, Partner, pendency, pipeline, promissory, Qualification, renewal, resided, resume, rollforward, sample, satisfaction, SetPoint, stable, step, suicidal, suicide, summary, suppressant, Tussionex, undiscounted, ZYLFO
Removed:
accrue, analyze, assistance, attempt, borrowing, bronchoconstriction, Brovana, cholinergic, citizen, close, collection, compound, counterclaimed, custom, deem, disclaim, educate, emphysema, European, expiring, financed, formal, IMI, invent, move, nebulized, nicotinic, parent, pharmacovigilance, refer, relegated, repaid, SA, scale, Sepracor, ship, succeed, sued, suspended, test, tolerability, write
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 2.2 EX-2.2 Amendment NO.1, Dated As of August 7, 2008, to Agreement and Plan of Merger, Dated As of May 1, 2008
- 2.4 EX-2.4 Merger Partner Noteholder Agreement, Dated As of May 1, 2008
- 2.5 EX-2.5 Amendment No. 1, Dated As of August 7, 2008, to Merger Partner Noteholder Agreement, Dated As of May 1, 2008
- 31.1 EX-31.1 Certification of the Principal Executive Officer Pursuant to Rule 13A-14(A) and 15D-14(A) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302
- 31.2 EX-31.2 Certification of the Principal Financial Officer Pursuant to Rule 13A-14(A) and 15D-14(A) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302
- 32.1 EX-32.1 Certification of the Principal Executive Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 32.2 EX-32.2 Certification of the Principal Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
Related press release
CRTX similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(b)
OF THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350
PURSUANT TO RULE 13a-14(b)
OF THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350
In connection with the Quarterly Report on Form 10-Q of Critical Therapeutics, Inc. (the “Company”) for the period ended June 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Trevor Phillips, Ph.D, President and Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | ||
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: August 11, 2008
President and Chief Executive Officer | ||||
(Principal Executive Officer) |